Inosi Therapeutics Pty Ltd
Inosi Therapeutics is developing therapies to address fibrosis, potentially preventing or reversing tissue damage, scarring and a loss of organ function in patients. Their novel inhibitors target a central pathway in fibrosis and inflammation, meeting a huge unmet need that could modify the progression of disease and potentially save lives.
Year established: 2019
Lead Researchers & Founders: Siew Chai, Tracey Gaspari, Phil Thompson and Rob Widdop
Website: inositherapeutics.com